Form 4 for BTSG BrightSpring Health Services, Inc.

Accepted 2024-01-30 00:00:00 ET · period of report 2024-01-25 · accession 0000950170-24-008830 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-01-30	2024-01-26	BTSG	REED STEVEN S	See Remarks	A - Grant	$0.00	+54.7K	93.9K	+139%	$0
DM	2024-01-30	2024-01-25	BTSG	REED STEVEN S	See Remarks	A - Grant	$0.00	+80.7K	19.8K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-01-26	A	A	54,658	$0.00	93,914	D	—	—
2	Derivative	Stock Options (Right to Buy)	2024-01-25	A	A	60,847	$0.00	182,543	D	$6.37 · — to 2029-09-24	60,847 Common Stock	(F2) Options acquired represent options originally granted on September 24, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining options are subject to a time-based vesting schedule, vesting in five equal annual installments commencing March 5, 2020. Reflects a 15.7027-for-1 forward stock split of the Issuer's common stock, which became effective on January 25, 2024. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria.
3	Derivative	Stock Options (Right to Buy)	2024-01-25	A	A	19,837	$0.00	19,837	D	$13.00 · — to 2034-01-25	19,837 Common Stock	(F3) Options granted on January 25, 2024 which vest in three equal annual installments commencing on January 25, 2025. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024.